Increase of CD25 expression on bovine neutrophils correlates with disease severity in post-partum and early lactating dairy cows

Developmental and Comparative Immunology

Volumn 47, Issue 2, 2014, Pages 254-263

  Zoldan, Katharina ^a   Moellmer, Theresa ^b   Schneider, Josephine ^a   Fueldner, Christiane ^a   Knauer, Jens ^a   Lehmann, Jörg ^a  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b Agriculture and Geology   (Germany)

Author keywords

Biomarker; Bovine neutrophil; CD25; Interleukin 2 receptor; PMN

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; BIOLOGICAL MARKER; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DAIRY CATTLE; DISEASE SEVERITY; FLOW CYTOMETRY; GRANULOCYTE; INNATE IMMUNITY; LACTATION; MOLECULAR DYNAMICS; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUERPERIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TH1 CELL; TH17 CELL; ANIMAL; BOVINE; BOVINE MASTITIS; CYTOLOGY; DAIRYING; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MILK; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TIME; UDDER; CATTLE DISEASE; CD25+ T LYMPHOCYTE; DISEASE MARKER; GENE; IL2RA GENE; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MASTITIS; PHAGOCYTOSIS;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; DAIRYING; FEMALE; GENE EXPRESSION; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LACTATION; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

BOVINAE;

EID: 84907338322     PISSN: 0145305X     EISSN: 18790089     Source Type: Journal    
DOI: 10.1016/j.dci.2014.08.002     Document Type: Article

References (65)

1. Abdel-Salam B.K.A.-H. Comparing effects of interleukin-2 and interleukin-4 on the expression of MHC class II, CD80 and CD86 on polymorphonuclear neutrophils. Egypt. J. Med. Hum. Genet 2010, 11:115-120.
2. Akin C., Metcalfe D.D. Surrogate markers of disease in mastocytosis. Int. Arch. Allergy Immunol 2002, 127:133-136.
3. Baars J.W., Hack C.E., Wagstaff J., Eerenberg-Belmer A.J., Wolbink G.J., Thijs L.G., et al. The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2. Br. J. Cancer 1992, 65:96-101.
4. Bank U., Reinhold D., Schneemilch C., Kunz D., Synowitz H.J., Ansorge S. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J. Interferon Cytokine Res 1999, 19:1277-1287.
5. Beyrau M., Bodkin J.V., Nourshargh S. Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol 2012, 2. published online. 10.1098/rsob.120134.
6. Bien E., Balcerska A. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review. Biomarkers 2008, 13:1-26.
7. Brown G.B., Roth J.A. Comparison of the response of bovine and human neutrophils to various stimuli. Vet. Immunol. Immunopathol 1991, 28:201-218.
8. Burvenich C., Paape M.J., Hill A.W., Guidry A.J., Miller R.H., Heyneman R., et al. Role of the neutrophil leucocyte in the local and systemic reactions during experimentally induced E.coli mastitis in cows immediately after calving. Vet. Q. 1994, 16:45-50.
9. Cabrera R., Ararat M., Cao M., Xu Y., Wasserfall C., Atkinson M., et al. Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25). Dig. Dis. Sci 2010, 55:484-495.
10. Cai T.Q., Weston P.G., Lund L.A., Brodie B., McKenna D.J., Wagner W.C. Association between neutrophil functions and periparturient disorders in cows. Am. J. Vet. Res 1994, 55:934-943.
11. Djeu J.Y., Liu J.H., Wei S., Rui H., Pearson C.A., Leonard W.J., et al. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J. Immunol 1993, 150:960-970.
12. Downes K., Marcovecchio M.L., Clarke P., Cooper J., Ferreira R., Howson J., et al. Plasma concentrations of soluble IL-2 receptor alpha (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients. Diabetologia 2014, 57:366-372.
13. Faurschou M., Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003, 5:1317-1327.
14. Gennaro R., Dewald B., Horisberger U., Gubler H.U., Baggiolini M. A novel type of cytoplasmic granule in bovine neutrophils. J. Cell Biol 1983, 96:1651-1661.
15. Girard D., Gosselin J., Heitz D., Paquin R., Beaulieu A.D. Effects of interleukin-2 on gene expression in human neutrophils. Blood 1995, 86:1170-1176.
16. Gray G.D., Knight K.A., Nelson R.D., Herron M.J. Chemotactic requirements of bovine leukocytes. Am. J. Vet. Res 1982, 43:757-759.
17. Harmon R.J. Physiology of mastitis and factors affecting somatic cell counts. J. Dairy Sci 1994, 77:2103-2112.
18. Hashimoto Y., Yokohama A., Saitoh A., Nakahashi H., Toyama K., Mitsui T., et al. Prognostic importance of the soluble form of IL-2 receptor alpha (sIL-2R alpha) and its relationship with surface expression of IL-2R alpha (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like Regimen with or without rituximab: a retrospective analysis of 338 cases. J. Clin. Exp. Hematol 2013, 53:197-205.
19. Herrmann F., Cannistra S.A., Levine H., Griffin J.D. Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. J. Exp. Med 1985, 162:1111-1116.
20. Hogeveen H., Ouweltjes W. Sensors and management support in high-technology milking. J. Anim. Sci 2003, 81:1-10.
21. Hogeveen H., Huijps K., Lam T.J.G.M. Economic aspects of mastitis: new developments. N. Z. Vet. J. 2011, 59:16-23.
22. Howard C.J., Naessens J. Summary of workshop findings for cattle (tables 1 and 2). Vet. Immunol. Immunopathol 1993, 39:25-47.
23. Howard C.J., Taylor G., Brownlie J. Surface receptors for immunoglobulin on bovine polymorphonuclear neutrophils and macrophages. Res. Vet. Sci 1980, 29:128-130.
24. Huang Z., Fang J., Gu J., Yan Y., Zhou J. Development of a capture ELISA to determine kinetics of soluble CD25 following in vitro and in vivo stimulation of duck peripheral blood monocytes. Vet. Immunol. Immunopathol 2011, 140:102-109.
25. Huefner M., Wermann M., Grußendorf M., Heilig B. Is soluble CD25 antigen (interleukin-2 receptor) a useful parameter for differential diagnosis of thyrotoxicosis?. Clin. Investig 1992, 70:122-124.
26. Ingvartsen K.L., Moyes K. Nutrition, immune function and health of dairy cattle. Anim 2013, 7:112-122.
27. Jablons D., Bolton E., Mertins S., Rubin M., Pizzo P., Rosenberg S.A., et al. IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis. J. Immunol 1990, 144:3630-3636.
28. Kehrli M.E., Nonnecke B.J., Roth J.A. Alterations in bovine neutrophil function during the periparturient period. Am. J. Vet. Res 1989, 50:207-214.
29. Kimura K., Goff J.P., Kehrli J. Effects of the presence of the mammary gland on expression of neutrophil adhesion molecules and myeloperoxidase activity in periparturient dairy cows. J. Dairy Sci 1999, 82:2385-2392.
30. Klempner M.S., Noring R., Mier J.W., Atkins M.B. An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N. Engl. J. Med 1990, 322:959-965.
31. Kobayashi H., Tagaya Y., Han E.S., Kim I.S., Le N., Paik C.H., et al. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2. Cytokine 1999, 11:1065-1075.
32. Koknaroglu H., Akunal T. Animal welfare: an animal science approach. Meat Sci 2013, 95:821-827.
33. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol 2013, 13:159-175.
34. Kowanko I.C., Ferrante A. Interleukin 2 inhibits migration and stimulates respiratory burst and degranulation of human neutrophils in vitro. Immunol. Lett 1987, 15:285-289.
35. Li J., Gyorffy S., Lee S., Kwok C. Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro. Inflammation 1996, 20:361-372.
36. Liu J.H., Wei S., Ussery D. Expression of interleukin-2 receptor γ chain on human neutrophils. Blood 1994, 84:3870-3875.
37. Maier L.M., Anderson D.E., Severson C.A., Baecher-Allan C., Healy B., Liu D.V., et al. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J. Immunol 2009, 182:1541-1547.
38. Mehrzad J., Dosogne H., Meyer E., Heyneman R., Burvenich C. Respiratory burst activity of blood and milk neutrophils in dairy cows during different stages of lactation. J. Dairy Sci 2001, 68:399-415.
39. Moreno S.E., Alves-Filho J.C., Bertozi G., Alfaya T.M., Thèze J., Ferreira S.H., et al. Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide. Br. J. Pharmacol 2006, 148:1060-1066.
40. Mosaad A.A., Elbagory A.R., Khalid A.M., Waters W.R., Tibary A., Hamilton M.J., et al. Identification of monoclonal antibody reagents for use in the study of immune response in camel and water buffalo. J. Camel Pract. Res 2006, 13:91-101.
41. Moxey-Mims M.M., Simms H.H., Frank M.M., Lin E.Y., Gaither T.A. The effects of IL-1, IL-2, and tumor necrosis factor on polymorphonuclear leukocyte Fc gamma receptor-mediated phagocytosis. IL-2 down-regulates the effect of tumor necrosis factor. J. Immunol 1991, 147:1823-1830.
42. Naessens J., Sileghem M., MacHugh N., Park Y.H., Davis W.C., Toye P. Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine p55-interleukin-2 (IL-2) receptor gene. Immunology 1992, 76:305-309.
43. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol 2006, 6:173-182.
44. Paape M.J., Bannerman D.D., Zhao X., Lee J.W. The bovine neutrophil: structure and function in blood and milk. Vet. Res 2003, 34:597-627.
45. Pericle F., Liu J.H., Blanchard D.K., Wei S., Djeu J.Y., Diaz J.I., et al. Interleukin-2 prevention of apoptosis in human neutrophils. Eur. J. Immunol 1994, 24:440-444.
46. Rainard P., Riollet C. Innate immunity of the bovine mammary gland. Vet. Res 2006, 37:369-400.
47. Rausch P.G., Moore T.G. Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison. Blood 1975, 46:913-919.
48. Reddy V.V., Myles A., Cheekatla S.S., Singh S., Aggarwal A. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis. Int. J. Rheum. Dis 2014, published online. 10.1111/1756-185X.12196.
49. Rinaldi M., Moroni P., Paape M.J., Bannerman D.D. Differential alterations in the ability of bovine neutrophils to generate extracellular and intracellular reactive oxygen species during the periparturient period. Vet. J. 2008, 178:208-213.
50. Saito K., Wagatsuma T., Toyama H., Ejima Y., Hoshi K., Shibusawa M., et al. Sepsis is characterized by the increases in percentages of circulating CD4+ CD25+ regulatory T cells and plasma levels of soluble CD25. Tohoku J. Exp. Med 2008, 216:61-68.
51. Salak J.L., McGlone J.J., Lyte M. Effects of in vitro adrenocorticotrophic hormone, cortisol and human recombinant interleukin-2 on porcine neutrophil migration and luminol-dependent chemiluminescence. Vet. Immunol. Immunopathol 1993, 39:327-337.
52. Silva M.T. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol 2010, 87:805-813.
53. Simenew K., Wondu M. Transition period and immunosuppression: critical period of dairy cattle reproduction. Int. J. Anim. Vet. Adv 2013, 5:44-57.
54. Smith S., Warren G.D., Thong Y.H., McCormack J.G. Suppression of monocyte and neutrophil function by recombinant IL-2. Mediators Inflamm 1993, 2:59-65.
55. Stevens P., Piazza D.E. Interleukin-2 increases the oxidative activity and induces migration of murine polymorphonuclear leukocytes in vivo. Int. J. Immunopharmacol 1990, 12:605-611.
56. Sugiyama H., Ono Y., Kunii O. Effect of recombinant human interleukin-2 on the chemotaxis and chemiluminescence of human polymorphonuclear leukocytes. J. Jpn. Assoc. Infect. Dis 1993, 67:1178-1182.
57. Summers C., Rankin S.M., Condliffe A.M., Singh N., Peters A.M., Chilvers E.R. Neutrophil kinetics in health and disease. Trends Immunol 2010, 31:318-324.
58. Van Oostveldt K., Vangroenweghe F., Dosogne H., Burvenich C. Apoptosis and necrosis of blood and milk polymorphonuclear leukocytes in early and midlactating healthy cows. Vet. Res 2001, 32:617-622.
59. Wei S., Blanchard D.K., Liu J.H., Leonard W.J., Djeu J.Y. Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta. J. Immunol 1993, 150:1979-1987.
60. Wei S., Liu J.H., Blanchard D.K., Djeu J.Y. Induction of IL-8 gene expression in human polymorphonuclear neutrophils by recombinant IL-2. J. Immunol 1994, 152:3630-3636.
61. Wei S., Liu J.H., Epling-Burnette P.K., Jiang K., Zhong B., Elkabani M.E., et al. IL-2 induces the association of IL-2Rbeta, lyn, and MAP kinase ERK-1 in human neutrophils. Immunobiology 2000, 202:363-382.
62. Whale T.A., Beskorwayne T.K., Babiuk L.A., Griebel P.J. Bovine polymorphonuclear cells passively acquire membrane lipids and integral membrane proteins from apoptotic and necrotic cells. J. Leukoc. Biol 2006, 79:1226-1233.
63. Yoshida N., Oda M., Kuroda Y., Katayama Y., Okikawa Y., Masunari T., et al. Clinical significance of sIL-2R levels in B-cell lymphomas. PLoS ONE 2013, 8:e78730.
64. Zhang G., Young J.R., Tregaskes C.A., Sopp P., Howard C.J. Identification of a novel class of mammalian Fc gamma receptor. J. Immunol 1995, 155:1534-1541.
65. Zhao X., Lacasse P. Mammary tissue damage during bovine mastitis: causes and control. J. Anim. Sci 2008, 86:57-65.